Dengue
148
13
19
91
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
32 trials with published results (22%)
Research Maturity
91 completed trials (61% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.1%
9 terminated out of 148 trials
91.0%
+4.5% vs benchmark
8%
12 trials in Phase 3/4
35%
32 of 91 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 91 completed trials
Clinical Trials (148)
Adaptive Dengue Antiviral Platform Trial
Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human Mobility
Therapeutics for Moderate and Severe Dengue
Demographic Characteristics of TAK-003 Dengue Vaccine Recipients in Vietnam
Using Digital Technology for the Prevention of Aedes-Borne Diseases in Colombian Communities
A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever
Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At Scale
Butantan-DV Vaccine in Elderly Populations (DEN-04-IB)
Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years.
A Controlled Human Infection Model of Dengue
Characterizing Humoral Immune Response to Mosquito Bites
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Immunogenicity of an Intradermal Qdenga Vaccine Among Healthy Volunteers
Anakinra in Dengue With Hyperinflammation ( AnaDen )
Emetine for Viral Outbreaks (a.k.a. EVOLVE Antiviral Initiative)
Pilot Study to Detect DENGUE Virus in Sperm
Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan - DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181 - 002)
Study to Examine the Effects of Oral Fenretinide
Dengue - Sample Collection Study Pakistan
Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases